secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO-RAD LABORATORIES, INC. (BIO)
CIK:        0000012208
Form:       8-K
Filed at:   2024-08-20T23:59:59+00:00
Accession:  0000012208-24-000054
Event type: leadership
Sentiment:  positive
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bio-Rad appoints Jon DiVincenzo as President and COO, replacing retiring Andy Last
--------------------------------------------------------------------------------

- DiVincenzo joins from Labcorp, where he was EVP and President, Central Laboratories & International.
- Start date September 9, 2024; Last retires September 5, 2024.
- Compensation includes $665k base salary, $2.5M RSU grant, $1.3M sign-on bonus, and relocation support.
- Norman Schwartz remains CEO and Chairman, no longer President.
- DiVincenzo brings 30+ years of life science and diagnostics experience.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/12208/000001220824000054/0000012208-24-000054-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/12208/000001220824000054/bio-20240815.htm
  HTML page:      https://secwatch.observer/filing/0000012208-24-000054

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer